Buprenorphine Market Expected to Witness High Growth Driven by Increasing Chronic Pain Prevalence and Growing Acceptance of Buprenorphine as a Pain Treatment Option
The buprenorphine market is estimated to be valued at US$ 3,681.9 million in 2022 and is expected to exhibit a CAGR of 14.5% over the …